| dc.contributor.author | ABDEL-RAHIM, Aly | |
| dc.contributor.author | Satman, Ilhan | |
| dc.contributor.author | MBANYA, Jean Claude | |
| dc.contributor.author | AL-SIFRI, Saud | |
| dc.date.accessioned | 2021-03-03T10:32:11Z | |
| dc.date.available | 2021-03-03T10:32:11Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | MBANYA J. C. , AL-SIFRI S., ABDEL-RAHIM A., Satman I., "Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach", DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.109, sa.2, ss.226-232, 2015 | |
| dc.identifier.issn | 0168-8227 | |
| dc.identifier.other | av_2327c9e9-c07e-4861-882f-4facba0a1b0d | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/28614 | |
| dc.identifier.uri | https://doi.org/10.1016/j.diabres.2015.04.030 | |
| dc.description.abstract | Aim: Hypoglycemia can be a concern for patients with type 2 diabetes when fasting during Ramadan. In this analysis, we assessed the incidence of symptomatic hypoglycemic events in fasting patients treated with gliclazide or dipeptidyl peptidase-4 (DPP-4) inhibitors. | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
| dc.title | Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach | |
| dc.type | Makale | |
| dc.relation.journal | DIABETES RESEARCH AND CLINICAL PRACTICE | |
| dc.contributor.department | Al Hada Mil Hosp , , | |
| dc.identifier.volume | 109 | |
| dc.identifier.issue | 2 | |
| dc.identifier.startpage | 226 | |
| dc.identifier.endpage | 232 | |
| dc.contributor.firstauthorID | 17964 | |
